Tejnaksh Healthcare (BOM:539428) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539428 Tejnaksh Healthcare Ltd BOM:539428
72 GF Score
Price ₹13.72
GF Value ₹20.94
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tejnaksh Healthcare Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Tejnaksh Healthcare Valuation Rank Related Terms

BOM:539428
72GF Score
Tejnaksh Healthcare Ltd BOM:539428
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?

Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued. The current stock price of ₹13.72 is trading 34.5% below its estimated GF Value™ of ₹20.94. GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.

Key valuation signals for BOM:539428:

  • Valuation Rank:
  • GF Value™: ₹20.94 vs. price of ₹13.72 (34.5% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tejnaksh Healthcare Business Description

Address Institute of Urology, Sakri Road, Dhule, MH, IND, 424 001
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
72GF Score

Get the complete analysis for BOM:539428

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.72
Price
₹20.94
GF Value